gastric cancer,esophageal cancer,colorectal tumor
Conditions
Interventions
For bleeding during endoscopic submucosal dissection, an oral rehydration jelly is injected to identify the bleeding site. There is no upper limit to the number and amount of jelly injections.
For ble
Sponsors
Department of Gastroenterology, Kanazawa University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who are scheduled for endoscopic submucosal dissection of the esophagus, stomach, and large intestine. 2) Age at the time of obtaining consent is 20 years old or older and less than 80 years old. 3) Informed consent has been obtained from the patient regarding participation in this study.
Exclusion criteria
Exclusion criteria: 1) Patients who are likely to have perforated or have perforated during endoscopic submucosal dissection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In Phase I, OS-1 jelly was used to improve the field of view and evaluate safety when hemostasis occurred. In Phase II, the time taken to identify the bleeding site in the normal group and jelly combination group. | — |
Countries
Japan
Contacts
Public ContactHajime Takatori
Kanazawa University Hospital Department of Gastroenterology
Outcome results
None listed